血清代谢物特征肝脏表型,并揭示共享的途径:基于人口的成像结果
Juliane Maushagen1,2, Johanna Nattenmüller1,3, Ricarda von Krüchten1
1Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Molecular medicine (Cambridge, Mass.)
|July 21, 2025
概括
与肝脏脂肪和铁过载相关的代谢物可以改善肥胖症和铁过载的诊断,揭示共享的代谢途径和铁过载.
科学领域:
- 代谢学 代谢学 代谢学
- 肝脏疾病 肝脏疾病
- 人口队列研究 人口队列研究
背景情况:
- 脂肪性肝病是一个重大的公共卫生问题.
- 肝脏的铁过载会使肝纤维化恶化.
- 识别代谢标记对于理解和管理这些疾病至关重要.
研究的目的:
- 为了确定与肝脏脂肪和/或铁过载相关的代谢物.
- 为了研究肥胖症和铁过载之间的共享代谢途径.
- 为了评估代谢物对肝脏疾病的诊断性能.
主要方法:
- 横截面研究 (KORA-MRI,N=376) 进行.
- 磁共振成像用于肝脏脂肪和铁的量化.
- 针对血清代谢物分析的向代谢物.
- 统计学关联分析,途径和调解分析.
主要成果:
- 多种代谢物,包括氨基酸和脂质,与肝脏脂肪和铁含量有关.
- 当被添加到脂肪肝指数 (FLI) 中时,特定代谢物改善了肥胖症和铁过载的诊断.
- 在肥胖症和铁过载之间确定了共享的途径 (例如,糖脂代谢).
结论:
- 代谢物与肝脏脂肪和铁水平显著相关.
- 这些代谢物具有共同的代谢途径.
- 代谢物分析提高了肥胖症和铁过载的诊断能力,强调了铁在肝脏疾病中的作用.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


